Statistics

Total Visits

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies64

Select a period of time:

Number of views in the range

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies10

Views

Views
November 20253
December 20250
January 20262
February 20260
March 20263
April 20261
May 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Brazil2
Argentina1
Cameroon1
Colombia1
Czech Republic1
Nigeria1
Togo1
 

Top cities views

Views
Abuja1
Baltimore1
Curitiba1
Douala1
Feira de Santana1
Lomé1
Middletown1
Prague1
San Juan1